Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

被引:791
作者
Emerson, J
Rosenfeld, M
McNamara, S
Ramsey, B
Gibson, RL
机构
[1] Childrens Hosp & Reg Med Ctr, Cyst Fibrosis Res Ctr, Seattle, WA 98105 USA
[2] Univ Washington, Div Pulm Med, Dept Pediat, Seattle, WA 98195 USA
关键词
cystic fibrosis; prognosis; survival; clinical outcomes; Pseudomonas aeruginosa; regression models; gender; epidemiology;
D O I
10.1002/ppul.10127
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We conducted a registry-based study to determine prognostic indicators of 8-year mortality and morbidity in young children with cystic fibrosis (CF). Patients ages 1-5 years from the 1990 U.S. Cystic Fibrosis Foundation (CFF) National Patient Registry served as the study cohort (N = 3,323). Registry data provided information on baseline characteristics in 1990, 8-year mortality, and clinical outcomes in 1998. P. aeruginosa respiratory infection was found to be a major predictor of morbidity and mortality. The 8-year risk of death was 2.6 times higher in patients who had respiratory cultures positive for P. aeruginosa in 1990 (95% confidence interval 1.6, 4.1) than in children without P. aeruginosa in their respiratory cultures. Culture-positive patients in 1990 also had a significantly lower percent predicted forced expiratory volume in 1 sec (FEV1) and weight percentile at follow-up, and they had an increased risk of continued P. aeruginosa respiratory infection and hospitalization for acute respiratory exacerbation in 1998. Among the other predictors of increased morbidity and mortality were lower baseline weight percentiles and number of CF-related hospitalizations during the baseline year. These findings confirm reports from previous smaller studies of outcomes among young children with CF, and highlight the potential to decrease the morbidity and mortality of young patients with CF through early intervention. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 27 条
[1]   EARLY BACTERIOLOGICAL, IMMUNOLOGICAL, AND CLINICAL COURSES OF YOUNG INFANTS WITH CYSTIC-FIBROSIS IDENTIFIED BY NEONATAL SCREENING [J].
ABMAN, SH ;
OGLE, JW ;
HARBECK, RJ ;
BUTLERSIMON, N ;
HAMMOND, KB ;
ACCURSO, FJ .
JOURNAL OF PEDIATRICS, 1991, 119 (02) :211-217
[2]  
Altman DG, 1991, Practical Statistics for Medical Research, DOI DOI 10.1002/SIM.4780101015
[3]  
CANTIN A, 1995, AM J RESP CRIT CARE, V151, P939
[4]  
Collet D., 1994, MODELLING SURVIVAL D, V1st
[5]   Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis [J].
Corey, M ;
Edwards, L ;
Levison, H ;
Knowles, M .
JOURNAL OF PEDIATRICS, 1997, 131 (06) :809-814
[6]   GENDER DIFFERENCES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA INFECTION [J].
DEMKO, CA ;
BYARD, PJ ;
DAVIS, PB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (08) :1041-1049
[7]   THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS [J].
FITZSIMMONS, SC .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :1-9
[8]  
Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO
[9]  
2-R
[10]   MUCOID PSEUDOMONAS-AERUGINOSA IS A MARKER OF POOR SURVIVAL IN CYSTIC-FIBROSIS [J].
HENRY, RL ;
MELLIS, CM ;
PETROVIC, L .
PEDIATRIC PULMONOLOGY, 1992, 12 (03) :158-161